Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

S-Amlosafe 1.25mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Amlodipine (1.25mg)

Overview S-Amlosafe 1.25mg Tablet

Amlodipine 1.25mg tablets, a calcium channel blocker, effectively manage hypertension and prevent angina. By reducing blood pressure and cardiac strain, it mitigates the risk of stroke and heart attack. This medication may be used independently or in conjunction with other treatments, with dosage determined by individual needs and condition severity. Timing of administration is flexible—with or without food—but consistency is key. Continuous use, as prescribed, is crucial, even with symptom absence, as hypertension often presents asymptomatically. Discontinuation may worsen the condition. Lifestyle modifications, including regular physical activity, weight management, and a balanced diet, enhance blood pressure control. Commonly reported side effects include headache, swelling, tiredness, nausea, stomach discomfort, and drowsiness. Persistent or bothersome side effects warrant medical consultation for potential mitigation strategies. Rare instances of lichenoid keratosis (a benign, skin lesion typically reddish-brown and appearing on sun-exposed skin) have been reported; inform your doctor if this occurs. Prior to commencing treatment, disclose any liver, heart, or kidney issues. Pregnant or lactating individuals should seek medical advice. Complete disclosure of all current medications, particularly those for cardiovascular conditions, is essential. Regular blood pressure monitoring ensures treatment efficacy.

Uses of S-Amlosafe 1.25mg Tablet

Managing angina pectoris and hypertension.

Major Benefits of S-Amlosafe 1.25mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the S-Amlosafe 1.25mg Tablet whole; do not crush, chew, or divide it. This medication can be administered with or without food, although consistent timing is recommended.

Common Side effects of S-Amlosafe 1.25mg Tablet:

  • Headache
  • Fatigue
  • Nausea
  • Abdominal pain
  • Sleepiness
  • Edema (swelling)

How to use S-Amlosafe 1.25mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. S-Amlosafe 1.25mg Tablets can be administered with or without food, though consistent timing is recommended.

How S-Amlosafe 1.25mg Tablet works:

Amlosafe 1.25mg tablets function as a calcium channel blocker, regulating elevated blood pressure. This effect is achieved by vasodilation, easing pressure on blood vessels and promoting improved circulation. For angina, the increased blood flow reduces cardiac workload, relaxing heart muscles. Consequently, oxygen delivery is optimized, mitigating the risk of angina episodes.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using S-Amlosafe 1.25mg Tablet concurrently with alcohol. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Amlosafe 1.25mg tablets may pose risks during pregnancy. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against potential risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Amlosafe 1.25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by S-Amlosafe 1.25mg Tablets, which can produce side effects including dizziness, headache, nausea, or fatigue, impacting concentration and driving safety.

KidneyKidneySAFE IF PRESCRIBED

Amlosafe 1.25mg tablets can be safely administered to individuals with kidney impairment; no dosage modification is necessary.

LiverLiverCAUTION

Amlosafe 1.25mg tablets require careful consideration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Amlosafe 1.25mg tablet therapy commences with a reduced initial dose in patients with liver disease, subsequently titrated upward gradually under close observation.

What if you forget to take S-Amlosafe 1.25mg Tablet :

Should you forget to take your S-Amlosafe 1.25mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About S-Amlosafe 1.25mg Tablet

LabelValue
Type of Compound Compounds derived from dihydropyridine carboxylic acids
Potential for Dependence None.
Type of Medication Heart-related

FAQs on S-Amlosafe 1.25mg Tablet

Amlosafe 1.25mg tablets begin to act immediately. Complete therapeutic benefit, however, may require several weeks. Continue taking the medication as prescribed, regardless of perceived improvement or lack thereof. Contact your physician if you experience any adverse effects or if your condition worsens.
Amlosafe 1.25mg tablets can occasionally cause pruritus in patients; this is infrequent. Consult your physician if you develop intense itching.
Studies have not shown S-Amlosafe 1.25mg Tablets to worsen kidney conditions. Standard dosages of S-Amlosafe 1.25mg Tablets are appropriate for patients with kidney disease. Indeed, its ability to reduce blood pressure helps protect kidneys from hypertension-related damage.
Amlosafe 1.25mg tablets may be administered at any time of day. Morning administration is generally recommended, though your physician might prescribe evening dosing. Maintaining a consistent daily intake time is crucial for both adherence and consistent therapeutic blood levels.
Continue using S-Amlosafe 1.25mg tablets for the duration prescribed by your physician. This may be a lifelong regimen. Discontinuing the medication, even with symptom improvement or controlled blood pressure, is inadvisable. Ceasing S-Amlosafe 1.25mg tablet use risks a return to elevated blood pressure and potential health deterioration.
S-Amlosafe 1.25mg Tablets do not contain beta-blocking agents. This medication is classified as a calcium channel blocker, reducing blood pressure by promoting vasodilation and easing blood flow.
Amlosafe 1.25mg tablets can, in rare instances, lead to severe adverse reactions. These include hepatic complications (jaundice, nausea, emesis, anorexia), pancreatitis (intense abdominal pain, nausea, vomiting), and recurring chest pain, potentially signaling a myocardial infarction. Nevertheless, such occurrences are infrequent. Your physician deemed the therapeutic advantage of this medication to outweigh any potential risks. Adhere to your doctor's instructions.
Always seek your physician's guidance before commencing any new medication, whether requiring a prescription or not, including supplements. Maintain a low-sodium, low-fat diet and follow your doctor's recommended lifestyle modifications. Refrain from consuming grapefruit or grapefruit juice while using S-Amlosafe 1.25mg Tablet. Cease smoking and alcohol consumption; these changes contribute to lower blood pressure and reduced cardiovascular risk.
Amlosafe 1.25mg tablets may induce edema in the lower extremities. Elevating the legs while seated may help alleviate this. Consult your physician if the swelling persists.
S-Amlosafe 1.25mg Tablet
8
MRP 10
21% off